MRSH
Marsh & McLennan Companies, Inc. NYSE Listed Dec 30, 1987$166.04
After hrs
$163.25
-0.06%
Mkt Cap $80.0B
52w Low $162.85
4.4% of range
52w High $235.78
50d MA $174.66
200d MA $187.10
P/E (TTM)
19.6x
EV/EBITDA
14.8x
P/B
5.3x
Debt/Equity
1.4x
ROE
-100.0%
P/FCF
18.1x
RSI (14)
—
ATR (14)
—
Beta
0.75
50d MA
$174.66
200d MA
$187.10
Avg Volume
3.2M
Marsh & McLennan Cos., Inc. is a professional services firm, which offers clients advice and solutions in risk, strategy and people. The company is headquartered in New York, New York and currently employs 65,000 full-time employees. The firm is the parent company of various risk advisors and specialty consultants, including Marsh, the insurance broker; Guy Carpenter, the risk and reinsurance specialist; Mercer, the provider of human resource and investment related financial advice and services, and Oliver Wyman Group, the management and economic consultancy. The company conducts business through two segments: Risk and Insurance Services, which includes risk management activities, as well as insurance and reinsurance broking and services, and Consulting includes health, retirement, talent and investments consulting services and products, and specialized management, economic and brand consulting services. The company conducts business in the Risk and Insurance Services segment through Marsh and Guy Carpenter. The company conducts business in the Consulting segment through Mercer and Oliver Wyman Group.
1166 Avenue of the Americas · New York City, NY 10036-2774 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | AMC | 3.22 | 3.29 | +2.2% | 182.57 | -0.4% | -3.7% | -4.4% | -2.0% | -3.9% | -4.7% | — |
| Jan 29, 2026 | AMC | 1.97 | 2.12 | +7.6% | 187.92 | +1.1% | +0.1% | +0.2% | +0.3% | +1.0% | -0.2% | — |
| Oct 16, 2025 | AMC | 1.78 | 1.85 | +3.9% | 186.48 | +0.2% | +1.7% | +1.8% | +1.3% | +1.5% | +0.9% | — |
| Jul 17, 2025 | AMC | 2.67 | 2.72 | +1.9% | 211.04 | +0.0% | +0.6% | -0.5% | -0.4% | -0.6% | -1.3% | — |
| Apr 17, 2025 | AMC | 3.02 | 3.06 | +1.3% | 220.07 | -0.7% | -3.6% | -0.2% | -0.5% | -0.5% | -0.4% | — |
| Jan 30, 2025 | AMC | 1.76 | 1.87 | +6.2% | 220.83 | -0.8% | -1.8% | -0.7% | +1.0% | +2.1% | +2.3% | — |
| Oct 17, 2024 | AMC | 1.61 | 1.63 | +1.2% | 226.92 | +1.1% | -1.0% | -2.1% | -2.2% | -1.5% | -2.0% | — |
| Jul 18, 2024 | AMC | 2.40 | 2.41 | +0.4% | 217.42 | +1.0% | -0.3% | +0.7% | +0.7% | +0.0% | -0.6% | — |
| Apr 18, 2024 | AMC | 2.80 | 2.89 | +3.2% | 201.73 | +0.4% | +0.3% | -0.1% | -0.0% | -0.4% | -0.1% | — |
| Jan 25, 2024 | AMC | 1.63 | 1.68 | +3.1% | 191.09 | -0.3% | +1.0% | -0.1% | +1.0% | +1.4% | +1.4% | — |
| Oct 19, 2023 | AMC | 1.39 | 1.47 | +5.8% | 191.00 | +0.0% | -1.7% | -2.4% | -1.1% | -1.1% | -2.0% | — |
| Jul 20, 2023 | AMC | 2.12 | 2.20 | +3.8% | 189.20 | +0.9% | +1.2% | +1.7% | +2.2% | +1.5% | +0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6 | Citigroup | Upgrade | Neutral → Buy | $200 | $167.27 | $168.18 | +0.5% | -2.0% | -0.7% | — | — | — |
| Apr 17 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $182.57 | $181.76 | -0.4% | -3.7% | -4.4% | -2.0% | -3.9% | -4.7% |
| Apr 14 | BofA Securities | Maintains | Underperform → Underperform | — | $173.55 | $172.49 | -0.6% | -0.4% | +0.8% | +5.2% | +1.3% | +0.6% |
| Apr 13 | Mizuho | Maintains | Neutral → Neutral | — | $168.15 | $168.83 | +0.4% | +3.2% | +2.8% | +4.0% | +8.6% | +4.5% |
| Apr 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $175.81 | $173.36 | -1.4% | -1.5% | -4.4% | -1.3% | -1.7% | -0.5% |
| Apr 9 | JP Morgan | Maintains | Overweight → Overweight | — | $175.81 | $173.36 | -1.4% | -1.5% | -4.4% | -1.3% | -1.7% | -0.5% |
| Apr 8 | Barclays | Maintains | Overweight → Overweight | — | $172.66 | $171.99 | -0.4% | +1.8% | +0.3% | -2.6% | +0.5% | +0.1% |
| Apr 7 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $174.82 | $175.18 | +0.2% | -1.2% | +0.6% | -1.0% | -3.8% | -0.7% |
| Apr 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $174.61 | $175.00 | +0.2% | +0.1% | -1.1% | +0.7% | -0.8% | -3.7% |
| Mar 11 | Barclays | Maintains | Overweight → Overweight | — | $174.00 | $174.35 | +0.2% | -0.0% | -1.8% | -1.1% | -0.1% | -1.2% |
| Feb 27 | Mizuho | Downgrade | Outperform → Neutral | — | $185.29 | $185.45 | +0.1% | +0.8% | +0.6% | -0.6% | -0.2% | -0.2% |
| Feb 17 | Raymond James | Upgrade | Outperform → Strong Buy | — | $174.06 | $177.16 | +1.8% | +1.0% | +2.3% | +2.8% | +3.0% | +1.7% |
| Feb 3 | Citigroup | Maintains | Neutral → Neutral | — | $188.25 | $187.18 | -0.6% | +0.1% | +0.8% | -0.4% | -1.7% | -9.1% |
| Feb 2 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $188.19 | $189.98 | +1.0% | +0.0% | +0.2% | +0.8% | -0.4% | -1.7% |
| Feb 2 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $188.19 | $189.98 | +1.0% | +0.0% | +0.2% | +0.8% | -0.4% | -1.7% |
| Jan 30 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $187.92 | $190.00 | +1.1% | +0.1% | +0.2% | +0.3% | +1.0% | -0.2% |
| Jan 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $187.92 | $190.00 | +1.1% | +0.1% | +0.2% | +0.3% | +1.0% | -0.2% |
| Jan 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $187.92 | $190.00 | +1.1% | +0.1% | +0.2% | +0.3% | +1.0% | -0.2% |
| Jan 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $182.70 | $182.81 | +0.1% | +0.3% | -0.2% | -0.2% | -0.9% | -1.7% |
| Jan 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $185.63 | $185.21 | -0.2% | -1.6% | -1.3% | -1.8% | -1.7% | -2.5% |
| Jan 8 | Barclays | Maintains | Overweight → Overweight | — | $182.90 | $182.82 | -0.0% | +2.2% | +1.7% | +1.5% | -0.1% | +0.2% |
| Jan 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $185.54 | $184.70 | -0.5% | -1.4% | +0.7% | +0.3% | +0.0% | -1.5% |
| Jan 7 | JP Morgan | Maintains | Overweight → Overweight | — | $185.54 | $184.70 | -0.5% | -1.4% | +0.7% | +0.3% | +0.0% | -1.5% |
| Jan 6 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $187.34 | $186.45 | -0.5% | -1.0% | -2.4% | -0.2% | -0.7% | -0.9% |
| Dec 4 | Citigroup | Maintains | Neutral → Neutral | — | $183.87 | $184.16 | +0.2% | -0.4% | -1.1% | -1.2% | -1.4% | -1.6% |
| Nov 20 | Barclays | Upgrade | Equal Weight → Overweight | — | $177.13 | $177.56 | +0.2% | +1.0% | +2.1% | +1.4% | +2.8% | +3.1% |
| Nov 3 | TD Cowen | Maintains | Hold → Hold | — | $178.15 | $175.95 | -1.2% | -0.6% | +1.3% | +0.1% | -0.9% | +1.1% |
| Nov 3 | BofA Securities | Downgrade | Neutral → Underperform | — | $178.15 | $175.95 | -1.2% | -0.6% | +1.3% | +0.1% | -0.9% | +1.1% |
| Oct 20 | Goldman Sachs | Upgrade | Sell → Neutral | — | $189.59 | $189.90 | +0.2% | +0.2% | -0.3% | -0.1% | -0.8% | -1.6% |
| Oct 17 | Evercore ISI | Maintains | Outperform → Outperform | — | $186.48 | $186.82 | +0.2% | +1.7% | +1.8% | +1.3% | +1.5% | +0.9% |
| Oct 17 | Keefe, Bruyette & Woods | Upgrade | Underperform → Market Perform | — | $186.48 | $186.82 | +0.2% | +1.7% | +1.8% | +1.3% | +1.5% | +0.9% |
| Oct 17 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $186.48 | $186.82 | +0.2% | +1.7% | +1.8% | +1.3% | +1.5% | +0.9% |
| Oct 9 | JP Morgan | Upgrade | Neutral → Overweight | — | $204.75 | $207.00 | +1.1% | +0.6% | +1.1% | +0.3% | +1.1% | -0.4% |
| Oct 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $203.84 | $204.22 | +0.2% | +0.4% | +1.1% | +1.6% | +0.7% | +1.6% |
| Oct 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $203.84 | $204.22 | +0.2% | +0.4% | +1.1% | +1.6% | +0.7% | +1.6% |
| Oct 8 | UBS | Maintains | Buy → Buy | — | $203.84 | $204.22 | +0.2% | +0.4% | +1.1% | +1.6% | +0.7% | +1.6% |
| Oct 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $201.34 | $202.20 | +0.4% | +1.2% | +1.7% | +2.3% | +2.8% | +2.0% |
| Aug 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $207.21 | $206.75 | -0.2% | +0.2% | +1.8% | +1.9% | +1.9% | +1.6% |
| Jul 21 | Keefe, Bruyette & Woods | Maintains | Underperform → Underperform | — | $212.28 | $211.55 | -0.3% | -1.1% | -0.9% | -1.2% | -1.9% | -0.9% |
| Jul 21 | UBS | Maintains | Buy → Buy | — | $212.28 | $211.55 | -0.3% | -1.1% | -0.9% | -1.2% | -1.9% | -0.9% |
| Oct 19 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $189.65 | $191.72 | +1.1% | +0.7% | -1.0% | -1.7% | -0.4% | -0.4% |
| Oct 19 | Raymond James | Maintains | Outperform → Outperform | — | $189.65 | $191.72 | +1.1% | +0.7% | -1.0% | -1.7% | -0.4% | -0.4% |
| Oct 19 | Citigroup | Maintains | Neutral → Neutral | — | $189.65 | $191.72 | +1.1% | +0.7% | -1.0% | -1.7% | -0.4% | -0.4% |
| Oct 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $193.08 | $193.40 | +0.2% | -0.2% | -0.1% | -1.1% | -1.1% | -0.3% |
| Oct 5 | Jefferies | Maintains | Hold → Hold | — | $191.12 | $191.12 | +0.0% | +0.4% | +1.2% | +1.0% | +0.8% | +0.9% |
| Jul 23 | Citigroup | Maintains | Neutral → Neutral | — | — | — | — | — | — | — | — | — |
| Jul 23 | Raymond James | Maintains | Outperform → Outperform | — | — | — | — | — | — | — | — | — |
| Jul 20 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $187.36 | $186.31 | -0.6% | +1.0% | +2.2% | +2.7% | +3.2% | +2.5% |
| Jul 20 | Wells Fargo | Maintains | Overweight → Overweight | — | $187.36 | $186.31 | -0.6% | +1.0% | +2.2% | +2.7% | +3.2% | +2.5% |
| Jul 20 | BofA Securities | Upgrade | Underperform → Neutral | — | $187.36 | $186.31 | -0.6% | +1.0% | +2.2% | +2.7% | +3.2% | +2.5% |
No insider trades available.
8-K
Unknown — 8-K Filing
Marsh's 8% adjusted EPS growth to $3.29 signals strong operational efficiency and profitability momentum, justifying confidence in management's ability to navigate market challenges and potentially supporting stock valuation.
Apr 16
8-K
Unknown — 8-K Filing
Marsh McLennan issued a press release on April 14, 2026, likely announcing quarterly earnings or significant company developments that investors should review to assess business performance and strategic direction.
Apr 14
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A newly hired executive at Marsh receives a $1.75M long-term incentive package starting 2027, signaling management confidence but creating near-term dilution and potential overpayment risk that investors should evaluate against operational improvements.
Mar 10
8-K · 5.02
!!! Very High
Marsh -- 8-K 5.02: Executive Change
Peter Harrison's appointment as director at Marsh strengthens board oversight and may signal the company's commitment to strengthening governance as it navigates evolving insurance market challenges.
Feb 25
8-K
Marsh -- 8-K Filing
Marsh has issued convertible notes, with the terms and form of the securities detailed in exhibits, providing the company with additional capital financing options.
Feb 19
Data updated apr 26, 2026 1:17pm
· Source: massive.com